Diagnosis of health care-associated infectious diseases.
This report aims to provide a comprehensive presentation of the global market for Healthcare-associated Infectious Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare-associated Infectious Disease Diagnostics. This report contains market size and forecasts of Healthcare-associated Infectious Disease Diagnostics in global, including the following market information:
Global Healthcare-associated Infectious Disease Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Healthcare-associated Infectious Disease Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Diagnosis of health care-associated infectious diseases.
We surveyed the Healthcare-associated Infectious Disease Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare-associated Infectious Disease Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Healthcare-associated Infectious Disease Diagnostics Market Segment Percentages, by Type, 2022 (%)
Urinary Tract Infections
Surgical Site Infections
Hospital-acquired Pneumonia
BloodStream Infections
Gastrointestinal Infections
Global Healthcare-associated Infectious Disease Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Healthcare-associated Infectious Disease Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
ASCs
Global Healthcare-associated Infectious Disease Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Healthcare-associated Infectious Disease Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Healthcare-associated Infectious Disease Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Healthcare-associated Infectious Disease Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Accelerate Diagnostics
BD
bioMrieux
Bio-Rad
DiaSorin Molecular
F. Hoffmann-La Roche
Luminex
Meridian Bioscience
OpGen
QIAGEN
Quidel
Thermo Fisher Scientific
Trinity Biotech
Danaher
Outline of Major Chapters:
Chapter 1: Introduces the definition of Healthcare-associated Infectious Disease Diagnostics, market overview.
Chapter 2: Global Healthcare-associated Infectious Disease Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Healthcare-associated Infectious Disease Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Healthcare-associated Infectious Disease Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Healthcare-associated Infectious Disease Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Healthcare-associated Infectious Disease Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Healthcare-associated Infectious Disease Diagnostics Overall Market Size
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size: 2022 VS 2029
2.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Healthcare-associated Infectious Disease Diagnostics Players in Global Market
3.2 Top Global Healthcare-associated Infectious Disease Diagnostics Companies Ranked by Revenue
3.3 Global Healthcare-associated Infectious Disease Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Healthcare-associated Infectious Disease Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Healthcare-associated Infectious Disease Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Healthcare-associated Infectious Disease Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Healthcare-associated Infectious Disease Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Urinary Tract Infections
4.1.3 Surgical Site Infections
4.1.4 Hospital-acquired Pneumonia
4.1.5 BloodStream Infections
4.1.6 Gastrointestinal Infections
4.2 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Healthcare-associated Infectious Disease Diagnostics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 ASCs
5.2 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Healthcare-associated Infectious Disease Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2029
6.3.2 US Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.3.3 Canada Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.3.4 Mexico Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2029
6.4.2 Germany Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.4.3 France Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.4.4 U.K. Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.4.5 Italy Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.4.6 Russia Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.4.8 Benelux Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2029
6.5.2 China Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.5.3 Japan Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.5.4 South Korea Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.5.6 India Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2029
6.6.2 Brazil Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.6.3 Argentina Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2029
6.7.2 Turkey Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.7.3 Israel Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
6.7.5 UAE Healthcare-associated Infectious Disease Diagnostics Market Size, 2018-2029
7 Healthcare-associated Infectious Disease Diagnostics Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.1.4 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Company Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.2.4 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Accelerate Diagnostics Key News & Latest Developments
7.3 BD
7.3.1 BD Company Summary
7.3.2 BD Business Overview
7.3.3 BD Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.3.4 BD Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.3.5 BD Key News & Latest Developments
7.4 bioMrieux
7.4.1 bioMrieux Company Summary
7.4.2 bioMrieux Business Overview
7.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.4.4 bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.4.5 bioMrieux Key News & Latest Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Company Summary
7.5.2 Bio-Rad Business Overview
7.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.5.4 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Bio-Rad Key News & Latest Developments
7.6 DiaSorin Molecular
7.6.1 DiaSorin Molecular Company Summary
7.6.2 DiaSorin Molecular Business Overview
7.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.6.4 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.6.5 DiaSorin Molecular Key News & Latest Developments
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Company Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.7.4 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann-La Roche Key News & Latest Developments
7.8 Luminex
7.8.1 Luminex Company Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.8.4 Luminex Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Luminex Key News & Latest Developments
7.9 Meridian Bioscience
7.9.1 Meridian Bioscience Company Summary
7.9.2 Meridian Bioscience Business Overview
7.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.9.4 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Meridian Bioscience Key News & Latest Developments
7.10 OpGen
7.10.1 OpGen Company Summary
7.10.2 OpGen Business Overview
7.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.10.4 OpGen Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.10.5 OpGen Key News & Latest Developments
7.11 QIAGEN
7.11.1 QIAGEN Company Summary
7.11.2 QIAGEN Business Overview
7.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.11.4 QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.11.5 QIAGEN Key News & Latest Developments
7.12 Quidel
7.12.1 Quidel Company Summary
7.12.2 Quidel Business Overview
7.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.12.4 Quidel Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.12.5 Quidel Key News & Latest Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Company Summary
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.13.4 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Thermo Fisher Scientific Key News & Latest Developments
7.14 Trinity Biotech
7.14.1 Trinity Biotech Company Summary
7.14.2 Trinity Biotech Business Overview
7.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.14.4 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.14.5 Trinity Biotech Key News & Latest Developments
7.15 Danaher
7.15.1 Danaher Company Summary
7.15.2 Danaher Business Overview
7.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.15.4 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2018-2023)
7.15.5 Danaher Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Healthcare-associated Infectious Disease Diagnostics Market Opportunities & Trends in Global Market
Table 2. Healthcare-associated Infectious Disease Diagnostics Market Drivers in Global Market
Table 3. Healthcare-associated Infectious Disease Diagnostics Market Restraints in Global Market
Table 4. Key Players of Healthcare-associated Infectious Disease Diagnostics in Global Market
Table 5. Top Healthcare-associated Infectious Disease Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Healthcare-associated Infectious Disease Diagnostics Product Type
Table 9. List of Global Tier 1 Healthcare-associated Infectious Disease Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Company Summary
Table 31. Abbott Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 32. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Accelerate Diagnostics Company Summary
Table 35. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 36. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Accelerate Diagnostics Key News & Latest Developments
Table 38. BD Company Summary
Table 39. BD Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 40. BD Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. BD Key News & Latest Developments
Table 42. bioMrieux Company Summary
Table 43. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 44. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. bioMrieux Key News & Latest Developments
Table 46. Bio-Rad Company Summary
Table 47. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 48. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Bio-Rad Key News & Latest Developments
Table 50. DiaSorin Molecular Company Summary
Table 51. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 52. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. DiaSorin Molecular Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Company Summary
Table 55. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 56. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. F. Hoffmann-La Roche Key News & Latest Developments
Table 58. Luminex Company Summary
Table 59. Luminex Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 60. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Luminex Key News & Latest Developments
Table 62. Meridian Bioscience Company Summary
Table 63. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 64. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Meridian Bioscience Key News & Latest Developments
Table 66. OpGen Company Summary
Table 67. OpGen Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 68. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. OpGen Key News & Latest Developments
Table 70. QIAGEN Company Summary
Table 71. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 72. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. QIAGEN Key News & Latest Developments
Table 74. Quidel Company Summary
Table 75. Quidel Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 76. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. Quidel Key News & Latest Developments
Table 78. Thermo Fisher Scientific Company Summary
Table 79. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 80. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. Thermo Fisher Scientific Key News & Latest Developments
Table 82. Trinity Biotech Company Summary
Table 83. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 84. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 85. Trinity Biotech Key News & Latest Developments
Table 86. Danaher Company Summary
Table 87. Danaher Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 88. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 89. Danaher Key News & Latest Developments
List of Figures
Figure 1. Healthcare-associated Infectious Disease Diagnostics Segment by Type in 2022
Figure 2. Healthcare-associated Infectious Disease Diagnostics Segment by Application in 2022
Figure 3. Global Healthcare-associated Infectious Disease Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Healthcare-associated Infectious Disease Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2022
Figure 8. By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BD Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
